title: Early thrombolysis for the treatment of acute myocardial infarction: a systematic review and economic evaluation.
authors.affiliation: Liverpool Reviews and Implementation Group, New Medical School, Liverpool, UK.
authors.forename: A
authors.initials: A
authors.lastname: Boland
authors.forename: Y
authors.initials: Y
authors.lastname: Dundar
authors.forename: A
authors.initials: A
authors.lastname: Bagust
authors.forename: A
authors.initials: A
authors.lastname: Haycox
authors.forename: R
authors.initials: R
authors.lastname: Hill
authors.forename: R
authors.initials: R
authors.lastname: Mujica Mota
authors.forename: T
authors.initials: T
authors.lastname: Walley
authors.forename: R
authors.initials: R
authors.lastname: Dickson
mesh_terms: D003362:Cost-Benefit Analysis; D004341:Drug Evaluation; D004638:Emergency Treatment / Q000191:economics; D005343:Fibrinolytic Agents / Q000009:adverse effects / Q000145:classification / Q000191:economics* / Q000627:therapeutic use*; D006760:Hospitalization / Q000191:economics; D006801:Humans; D009203:Myocardial Infarction / Q000188:drug therapy* / Q000191:economics; D016032:Randomized Controlled Trials as Topic; D011994:Recombinant Proteins / Q000009:adverse effects / Q000191:economics / Q000627:therapeutic use; D013300:Streptokinase / Q000009:adverse effects / Q000191:economics / Q000627:therapeutic use; D000077785:Tenecteplase; D015912:Thrombolytic Therapy / Q000191:economics*; D013997:Time Factors; D010959:Tissue Plasminogen Activator / Q000009:adverse effects / Q000191:economics / Q000627:therapeutic use; D016896:Treatment Outcome
chemical_list: D005343:Fibrinolytic Agents; D011994:Recombinant Proteins; C087896:reteplase; D013300:Streptokinase; D010959:Tissue Plasminogen Activator; D000077785:Tenecteplase